Literature DB >> 12701066

Changes in markers of vascular injury in response to transient hyperhomocysteinemia.

Robert W Powers1, Alana K Majors, Stacy L Cerula, Heather A Huber, Brian P Schmidt, James M Roberts.   

Abstract

The purpose of this study was to test whether transient increases in homocysteine would promote changes in markers of endothelial injury, cellular fibronectin (cFN), and soluble vascular cell adhesion molecule 1 (sVCAM-1). Homocysteine, cFN, and sVCAM-1 concentrations increased significantly in response to a methionine load by 6 hours in human subjects. However, no correlation was observed between homocysteine and cFN or sVCAM-1. To directly test whether homocysteine can injure endothelial cells, human umbilical vein endothelial cells (HUVEC) were incubated with increasing concentrations of homocysteine, plasma, or serum from hyperhomocysteinemic mice or from the methionine-loaded test subjects. cFN release was increased from endothelial cells cultured with plasma (but not serum) of hyperhomocysteinemic transgenic mice or from methionine-loaded human subjects. These data suggest that very high homocysteine concentrations can promote endothelial injury; however, this effect is likely mediated by secondary effects that include a factor(s) present in plasma that affects endothelial cells. Copyright 2003 Elsevier, Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12701066     DOI: 10.1053/meta.2003.50081

Source DB:  PubMed          Journal:  Metabolism        ISSN: 0026-0495            Impact factor:   8.694


  2 in total

1.  Increased endothelin-1 reactivity and endothelial dysfunction in carotid arteries from rats with hyperhomocysteinemia.

Authors:  C R de Andrade; P F Leite; A C Montezano; D A Casolari; A Yogi; R C Tostes; R Haddad; M N Eberlin; F R M Laurindo; H P de Souza; F M A Corrêa; A M de Oliveira
Journal:  Br J Pharmacol       Date:  2009-04-09       Impact factor: 8.739

2.  Protocatechuic aldehyde inhibits TNF-α-induced fibronectin expression in human umbilical vein endothelial cells via a c-Jun N-terminal kinase dependent pathway.

Authors:  Yue-Feng Tong; Yong Liu; Zhi-Xing Hu; Zhe-Cheng Li; Agula A
Journal:  Exp Ther Med       Date:  2015-11-25       Impact factor: 2.447

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.